Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $43.4400 (3.65%) ($43.4400 - $43.4400) on Tue. Aug. 8, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.59% (three month average) | RSI | 60 | Latest Price | $43.4400(3.65%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.5% a day on average for past five trading days. | Weekly Trend | HALO declines -0.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) XBI(39%) BNDX(30%) IBB(30%) IGOV(25%) XLV(21%) | Factors Impacting HALO price | HALO will decline at least -1.295% in a week (0% probabilities). INDA(-31%) TBT(-19%) SKYY(-19%) EWY(-18%) URA(-15%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.295% (StdDev 2.59%) | Hourly BBV | 2.8 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $42.54(2.12%) | 10 Day Moving Average | $42.87(1.33%) | 20 Day Moving Average | $42.02(3.38%) | To recent high | -0.8% | To recent low | 44.1% | Market Cap | $5.937b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |